About
Abridge builds an enterprise AI platform that captures patient-clinician conversations and converts them into structured, billable clinical documentation. It sells primarily to healthcare systems and differentiates through real-time EHR integrations, auditable AI, and Linked Evidence that maps generated summaries to source conversation evidence.
Market
Abridge competes in the healthcare ambient AI and clinical documentation market, converting patient-clinician conversations into structured, EMR-integrated clinical notes. It positions itself as an enterprise-grade, AI-native platform for health systems, differentiating through healthcare-specific ASR and purpose-built LLMs, multilingual performance, Linked Evidence that connects summaries to source transcript/audio, and deep clinical and EMR integration.
Abridge primarily targets large healthcare enterprises and health systems seeking enterprise-grade clinical documentation and ambient AI, including organizations with complex EMR environments and large clinician populations. Key users and buyers are clinicians, health-system clinical leadership, and enterprise healthcare IT/operations teams; the platform also supports patients through more understandable visit documentation and follow-up insights.
At a Glance
Problem
Abridge addresses the administrative burden of clinical documentation: clinicians spend substantial time converting patient encounters into notes, while traditional documentation solutions can be too expensive or slow for modern health systems. Patients face a parallel problem because conventional records often fail to clearly capture the key details of a care plan. The central economic opportunity is to return clinician time to patient care, with the killer use case being automatic documentation of the encounter immediately after—or during—the visit.
Product / Service
Abridge is an enterprise AI platform for clinical conversations. Its software uses ambient listening to capture the patient-clinician conversation, creates a transcript, identifies speakers and language, structures the discussion around clinically relevant information, and generates contextually aware, clinically useful, and billable notes. Additional models verify the accuracy of the note and support efficient editing, while the platform can integrate into existing workflows and electronic health records.
The delivery model is designed for health systems rather than only individual clinicians: Abridge Enterprise provides centralized tools for security, compliance, and deployment across clinicians. The resulting notes can reduce documentation time, support actionable care plans and reminders for patients, and enable clinicians to spend more time on care instead of administrative work.
Market
Abridge competes in the enterprise healthcare AI, ambient clinical intelligence, and AI medical-scribe market. The category includes products that listen to clinical encounters and turn them into structured documentation; Ambience Healthcare is a named competitor in the available research. Abridge is also extending beyond point documentation toward a broader AI clinical assistant and clinician-intelligence platform serving patients, providers, payers, and health systems.
The evidence indicates meaningful commercial and market traction rather than a pre-revenue concept: Abridge announced an enterprise agreement giving thousands of clinicians at Yale New Haven Health access to the product, partnered with Google Cloud, and was recognized as a 2025 and 2026 Best in KLAS market leader in ambient AI. It also announced a $150 million financing round. The available evidence does not provide revenue or ARR figures, so the company's precise financial scale cannot be determined.
Founders & Leadership
Funding History
Union Square Ventures, Pillar Ventures
Wittington Ventures
Spark Capital
Lightspeed Venture Partners, Redpoint Ventures
Elad Gil, IVP
Andreessen Horowitz (a16z)
Andreessen Horowitz (a16z)
Recent News
Abridge acquired Altrina, a company that builds AI agents to automate multi-step workflows across industries. The acquisition expands Abridge’s clinical platform toward agentic workflow automation.
CHRISTUS Health expanded its relationship with Abridge through an unlimited enterprise agreement, extending the platform across inpatient care and launching a nursing documentation pilot.
NVIDIA and Abridge are collaborating on a healthcare-specific foundation model tailored to clinical conversations. The model is intended to improve accuracy, reliability, auditability, and customization across clinical workflows.
Abridge introduced a patient-centered clinician intelligence platform connecting care delivery, payment, and evidence-based workflows. The launch included an NVIDIA collaboration on a foundation model purpose-built for clinical conversations.
Eli Lilly made a strategic investment in Abridge to support evidence-based care and research access. Abridge also announced expanded capabilities connecting clinical conversations with payer, life-science, and clinical-trial workflows; the investment amount was not disclosed.
Abridge partnered with the New England Journal of Medicine and JAMA to bring peer-reviewed evidence into clinical workflows before, during, and after patient conversations.
Abridge expanded its clinical decision-support capabilities through a partnership with Wolters Kluwer’s UpToDate and additional content integrations.
Abridge closed a $316 million Series E extension at a reported $5.3 billion valuation, bringing its cumulative funding to roughly $830 million according to contemporaneous coverage.
UCHealth expanded Abridge across care sites following a nine-month pilot involving 250 providers. The rollout supports systemwide clinical documentation and the development of new inpatient documentation workflows.
Abridge and Availity began developing real-time prior-authorization workflows that use shared clinical context from patient conversations to support administrative processes and improve payer-provider coordination.
Active Roles
40Business Model
Abridge sells negotiated B2B enterprise subscription licenses to healthcare organizations, principally health systems, with reported pricing of approximately $2,500 per clinician annually or $199 per seat monthly. Additional commercial opportunities include extending its conversational-intelligence platform to payers and life-sciences organizations.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
Andreessen Horowitz, Lightspeed Venture Partners, Khosla Ventures, IVP, Redpoint Ventures, Spark Capital, CVS Health Ventures, Kaiser Permanente Ventures, Mass General Brigham Ventures